MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells

Significance Gains of the MYC gene are the most common imbalances in cancer and are associated with poor prognosis, particularly in B-cell lymphoma. Recent advances in DNA sequencing have revealed the existence of thousands of long noncoding RNAs (lncRNAs) with unknown functional relevance. We have here identified a MYC-regulated lncRNA that we named MYC-induced long noncoding RNA (MINCR) that has a strong correlation with MYC expression in cancer. We show that MINCR is functional and controls cell cycle progression by influencing the expression of MYC-regulated cell cycle genes. MINCR is, therefore, a novel player in MYC’s transcriptional network, with the potential to open new therapeutic windows in the fight against malignant lymphoma and, possibly, all cancers that rely on MYC expression. Despite the established role of the transcription factor MYC in cancer, little is known about the impact of a new class of transcriptional regulators, the long noncoding RNAs (lncRNAs), on MYC ability to influence the cellular transcriptome. Here, we have intersected RNA-sequencing data from two MYC-inducible cell lines and a cohort of 91 B-cell lymphomas with or without genetic variants resulting in MYC overexpression. We identified 13 lncRNAs differentially expressed in IG-MYC-positive Burkitt lymphoma and regulated in the same direction by MYC in the model cell lines. Among them, we focused on a lncRNA that we named MYC-induced long noncoding RNA (MINCR), showing a strong correlation with MYC expression in MYC-positive lymphomas. To understand its cellular role, we performed RNAi and found that MINCR knockdown is associated with an impairment in cell cycle progression. Differential gene expression analysis after RNAi showed a significant enrichment of cell cycle genes among the genes down-regulated after MINCR knockdown. Interestingly, these genes are enriched in MYC binding sites in their promoters, suggesting that MINCR acts as a modulator of the MYC transcriptional program. Accordingly, MINCR knockdown was associated with a reduction in MYC binding to the promoters of selected cell cycle genes. Finally, we show that down-regulation of Aurora kinases A and B and chromatin licensing and DNA replication factor 1 may explain the reduction in cellular proliferation observed on MINCR knockdown. We, therefore, suggest that MINCR is a newly identified player in the MYC transcriptional network able to control the expression of cell cycle genes.

[1]  P. Rosenberg,et al.  Female breast cancer incidence among Asian and Western populations: more similar than expected. , 2015, Journal of the National Cancer Institute.

[2]  Hansjuerg Alder,et al.  MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression , 2015, Oncotarget.

[3]  C. Croce,et al.  Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. , 2015, Journal of the National Cancer Institute.

[4]  K. Kok,et al.  Long noncoding RNAs as a novel component of the Myc transcriptional network , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  S. Srivastava,et al.  A long noncoding RNA connects c-Myc to tumor metabolism , 2014, Proceedings of the National Academy of Sciences.

[6]  K. Morris,et al.  MYC regulates the non-coding transcriptome , 2014, Oncotarget.

[7]  Z. Cournia,et al.  Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer. , 2014, Journal of the National Cancer Institute.

[8]  Ding Ma,et al.  Sine oculis homeobox homolog 1 promotes DNA replication and cell proliferation in cervical cancer. , 2014, International journal of oncology.

[9]  Aristotelis Tsirigos,et al.  Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia , 2014, Cell.

[10]  L. Zender,et al.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.

[11]  Marco J. Morelli,et al.  Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis , 2014, Nature.

[12]  D. Sargent,et al.  Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147. , 2014, Journal of the National Cancer Institute.

[13]  W. Ichikawa,et al.  MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits. , 2014, Biochimica et biophysica acta.

[14]  Ivan G. Costa,et al.  The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification , 2014, Nucleic acids research.

[15]  R. Spang,et al.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma , 2014, Haematologica.

[16]  R. Spang,et al.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. , 2014, Blood.

[17]  O. Petrenko,et al.  Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas , 2014, Proceedings of the National Academy of Sciences.

[18]  Howard Y. Chang,et al.  Essential role of lncRNA binding for WDR5 maintenance of active chromatin and embryonic stem cell pluripotency , 2014, eLife.

[19]  Andrea Tanzer,et al.  A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection , 2014, Genome Biology.

[20]  Michael Morse,et al.  Multiple knockout mouse models reveal lincRNAs are required for life and brain development , 2013, eLife.

[21]  Peter F. Stadler,et al.  Alu Elements in ANRIL Non-Coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions through Trans-Regulation of Gene Networks , 2013, PLoS genetics.

[22]  Yunlong Liu,et al.  NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets , 2013, Bioinform..

[23]  David Haussler,et al.  ENCODE Data in the UCSC Genome Browser: year 5 update , 2012, Nucleic Acids Res..

[24]  R. Spang,et al.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing , 2012, Nature Genetics.

[25]  Q. Zhan,et al.  Long non‐coding RNA gadd7 interacts with TDP‐43 and regulates Cdk6 mRNA decay , 2012, The EMBO journal.

[26]  Piero Carninci,et al.  Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat , 2012, Nature.

[27]  D. Green,et al.  c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells , 2012, Cell.

[28]  Charles Y. Lin,et al.  Transcriptional Amplification in Tumor Cells with Elevated c-Myc , 2012, Cell.

[29]  David G. Knowles,et al.  The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.

[30]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[31]  Kun Qu,et al.  BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration. , 2012, Genome research.

[32]  Howard Y. Chang,et al.  Suppression of progenitor differentiation requires the long noncoding RNA ANCR. , 2012, Genes & development.

[33]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[34]  Pieter C. Dorrestein,et al.  ncRNA- and Pc2 Methylation-Dependent Gene Relocation between Nuclear Structures Mediates Gene Activation Programs , 2011, Cell.

[35]  R. Spang,et al.  Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma , 2011, PloS one.

[36]  I. Iaccarino,et al.  Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc. , 2011, Journal of proteome research.

[37]  Cole Trapnell,et al.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. , 2011, Genes & development.

[38]  John T. Wei,et al.  Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression , 2011, Nature Biotechnology.

[39]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[40]  Howard Y. Chang,et al.  Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes , 2010, Science.

[41]  J. Rinn,et al.  A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response , 2010, Cell.

[42]  Hong Liu,et al.  Therapeutic potential of a synthetic lethal interaction between the MYC proto-oncogene and inhibition of aurora-B kinase , 2010, Proceedings of the National Academy of Sciences.

[43]  Christopher B. Burge,et al.  c-Myc Regulates Transcriptional Pause Release , 2010, Cell.

[44]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[45]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[46]  C. Dang,et al.  Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model , 2010, Proceedings of the National Academy of Sciences.

[47]  Julian Downward,et al.  Modulation of Cellular Migration and Survival by c-Myc through the Downregulation of Urokinase (uPA) and uPA Receptor , 2010, Molecular and Cellular Biology.

[48]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[49]  C. Bond,et al.  Paraspeckles: nuclear bodies built on long noncoding RNA , 2009, The Journal of cell biology.

[50]  Peter F. Stadler,et al.  Fast Mapping of Short Sequences with Mismatches, Insertions and Deletions Using Index Structures , 2009, PLoS Comput. Biol..

[51]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[52]  Howard Y. Chang,et al.  Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAs , 2007, Cell.

[53]  Richard A Young,et al.  Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.

[54]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[55]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[56]  J. Mattick,et al.  Non-coding RNA. , 2006, Human molecular genetics.

[57]  T. Pandita,et al.  Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53 , 2005, Oncogene.

[58]  S. Salzberg,et al.  The Transcriptional Landscape of the Mammalian Genome , 2005, Science.

[59]  Michael Q. Zhang,et al.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  D. Livingston,et al.  MYC recruits the TIP60 histone acetyltransferase complex to chromatin , 2003, EMBO reports.

[61]  Andrea Cocito,et al.  Genomic targets of the human c-Myc protein. , 2003, Genes & development.

[62]  E. Haralambieva,et al.  Detection of three common translocation breakpoints in non‐Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin‐embedded tissue sections , 2002, The Journal of pathology.

[63]  C. Dang,et al.  Translocations involving c-myc and c-myc function , 2001, Oncogene.

[64]  J. Aster,et al.  Molecular biology of Burkitt's lymphoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[65]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[66]  U. Weidle,et al.  Control of cell growth by c-Myc in the absence of cell division , 1999, Current Biology.

[67]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[68]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[69]  J. Lee,et al.  Genetic analysis of the mouse X inactivation center defines an 80-kb multifunction domain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  M. Cole,et al.  The Novel ATM-Related Protein TRRAP Is an Essential Cofactor for the c-Myc and E2F Oncoproteins , 1998, Cell.

[71]  R. Jaenisch,et al.  The (epi)genetic control of mammalian X-chromosome inactivation. , 1997, Current opinion in genetics & development.

[72]  H. Willard,et al.  Characterization of a murine gene expressed from the inactive X chromosome , 1991, Nature.

[73]  R. Smith,et al.  Burkitt's lymphoma. , 1986, International journal of pediatric otorhinolaryngology.

[74]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.